MedTrace Logo

Floseal Treatment for Posterior Epistaxis Study

NCT01098578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-01-26

Study results available
· View outcomes & findings →

Summary

Effectiveness of Floseal for the treatment of posterior epistaxis.

Conditions

Interventions

DRUG

Floseal

Received 1 syringe of Floseal as treatment for posterior epistaxis.

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Shaun Kilty, MD · Ottawa Hospital Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-11-30
Completion
2011-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098578 on ClinicalTrials.gov